Skip to main content

Hennion & Walsh Asset Management, Inc.

Position in AXSM — Axsome Therapeutics, Inc.

CIK 1861642 Parsippany, NJ

Position in AXSM

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$6,191,709
-$819,110 QoQ
Shares Held
36,633
-4.6% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in AXSM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Hennion & Walsh Asset Management, Inc. holds $181,506,492 across 60 Biotechnology names. AXSM ranks #8 (3.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 AXSM
Axsome Therapeutics, Inc.
This page
36,633 $6,191,709

All Filings in AXSM

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,191,709 36,633
2025-12-31 $7,010,819 38,386
2025-09-30 $5,697,948 46,916
2025-06-30 $5,209,061 49,900
2025-03-31 $6,913,009 59,273
2024-12-31 $4,893,503 57,836
2024-09-30 $5,225,760 58,148
2024-06-30 $5,207,142 64,685
2024-03-31 $5,544,743 69,483
2023-12-31 $4,824,427 60,616
2023-09-30 $4,685,844 67,046
2023-06-30 $5,564,622 77,437
2023-03-31 $5,814,203 94,264
2022-12-31 $7,187,744 93,190
2022-09-30 $4,755,688 106,582
2022-06-30 $3,772,167 98,490
2022-03-31 $4,351,620 105,137
2021-12-31 $3,590,875 95,047
2021-09-30 $2,643,754 80,211
2021-06-30 $5,142,273 76,227
2021-03-31 $3,293,755 58,173